Epibiotech Co., Ltd. (XKON:446440)
14,000
+30 (0.21%)
At close: Mar 27, 2026
28.09% (1Y)
| Market Cap | 32.30B +17.3% |
| Revenue (ttm) | 449.62M +15.9% |
| Net Income | -5.06B |
| EPS | -2,966.00 |
| Shares Out | 2.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7 |
| Average Volume | 14 |
| Open | 14,000 |
| Previous Close | 13,970 |
| Day's Range | 14,000 - 14,000 |
| 52-Week Range | 9,600 - 19,000 |
| Beta | 0.98 |
| RSI | 45.88 |
| Earnings Date | n/a |